scholarly journals Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene e6-promoter activity of epidermodysplasia verruciformis-associated human papillomavirus type 8

Virology ◽  
2003 ◽  
Vol 308 (2) ◽  
pp. 279-290 ◽  
Author(s):  
Baki Akgül ◽  
Peter Karle ◽  
Maja Adam ◽  
Pawel G Fuchs ◽  
Herbert J Pfister
Cancers ◽  
2018 ◽  
Vol 10 (8) ◽  
pp. 250 ◽  
Author(s):  
Vanesa Gottifredi ◽  
Lisa Wiesmüller

The tumor suppressor p53 is a transcriptional factor broadly mutated in cancer. Most inactivating and gain of function mutations disrupt the sequence-specific DNA binding domain, which activates target genes. This is perhaps the main reason why most research has focused on the relevance of such transcriptional activity for the prevention or elimination of cancer cells. Notwithstanding, transcriptional regulation may not be the only mechanism underlying its role in tumor suppression and therapeutic responses. In the past, a direct role of p53 in DNA repair transactions that include the regulation of homologous recombination has been suggested. More recently, the localization of p53 at replication forks has been demonstrated and the effect of p53 on nascent DNA elongation has been explored. While some data sets indicate that the regulation of ongoing replication forks by p53 may be mediated by p53 targets such as MDM2 (murine double minute 2) and polymerase (POL) eta other evidences demonstrate that p53 is capable of controlling DNA replication by directly interacting with the replisome and altering its composition. In addition to discussing such findings, this review will also analyze the impact that p53-mediated control of ongoing DNA replication has on treatment responses and tumor suppressor abilities of this important anti-oncogene.


2018 ◽  
Vol 10 (S33) ◽  
pp. S3895-S3898 ◽  
Author(s):  
Eekhoon Jho
Keyword(s):  

1998 ◽  
Vol 5 (8) ◽  
pp. 669-677 ◽  
Author(s):  
Tim L Beumer ◽  
Hermien L Roepers-Gajadien ◽  
Iris S Gademan ◽  
Paul PW van Buul ◽  
Gabriel Gil-Gomez ◽  
...  

Virology ◽  
2002 ◽  
Vol 295 (1) ◽  
pp. 74-85 ◽  
Author(s):  
Alexandra Eichten ◽  
Matthew Westfall ◽  
Jennifer A. Pietenpol ◽  
Karl Münger

Author(s):  
Di Shi ◽  
Peng Jiang

As a key transcription factor, the evolutionarily conserved tumor suppressor p53 (encoded by TP53) plays a central role in response to various cellular stresses. A variety of biological processes are regulated by p53 such as cell cycle arrest, apoptosis, senescence and metabolism. Besides these well-known roles of p53, accumulating evidence show that p53 also regulates innate immune and adaptive immune responses. p53 influences the innate immune system by secreted factors that modulate macrophage function to suppress tumourigenesis. Dysfunction of p53 in cancer affects the activity and recruitment of T and myeloid cells, resulting in immune evasion. p53 can also activate key regulators in immune signaling pathways which support or impede tumor development. Hence, it seems that the tumor suppressor p53 exerts its tumor suppressive effect to a considerable extent by modulating the immune response. In this review, we concisely discuss the emerging connections between p53 and immune responses, and their impact on tumor progression. Understanding the role of p53 in regulation of immunity will help to developing more effective anti-tumor immunotherapies for patients with TP53 mutation or depletion.


Author(s):  
Brittany M. Flowers ◽  
Patty B. Garcia ◽  
Barbara M. Grüner ◽  
Monte M. Winslow ◽  
Laura D. Attardi

Sign in / Sign up

Export Citation Format

Share Document